LncRNA AGPG confers endocrine resistance in breast cancer by promoting E2F1 activity. Yu S, Wang Y, Gong X, Fan Z, et al. Cancer Res 2023 Jul 18:CAN-23-0015. doi: 10.1158/0008-5472.CAN-23-0015.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu S, Wang Y, Gong X, Fan Z, et al. LncRNA AGPG confers endocrine resistance in breast cancer by promoting E2F1 activity. Cancer Res 2023 Jul 18:CAN-23-0015. doi: 10.1158/0008-5472.CAN-23-0015.
PMID: 37463119